158 related articles for article (PubMed ID: 10392173)
1. [Efficacy and toxicity spectrum of continuous infusion of 5-fluorouracil compared with bolus administration in advanced colorectal tumors].
Rödel C
Strahlenther Onkol; 1999 Jun; 175(6):294-5. PubMed ID: 10392173
[No Abstract] [Full Text] [Related]
2. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
de Gramont A; Louvet C; Krulik M
J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
[TBL] [Abstract][Full Text] [Related]
3. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
4. 5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.
Hejna M; Kornek GV; Raderer M; Valencak J; Weinländer G; Fiebiger W; Miholic J; Scheithauer W
Ann Oncol; 1998 Dec; 9(12):1309-14. PubMed ID: 9932161
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion.
Cremona F; Izzo F; Ruffolo F; Palaia R; Parisi V
J Chemother; 1997 Apr; 9(2):140-1. PubMed ID: 9176762
[No Abstract] [Full Text] [Related]
6. Which 5-fluorouracil regimen?--the great debate.
Vincent M; Labianca R; Harper P
Anticancer Drugs; 1999 Apr; 10(4):337-54. PubMed ID: 10378668
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.
; Piedbois P; Rougier P; Buyse M; Pignon J; Ryan L; Hansen R; Zee B; Weinerman B; Pater J; Leichman C; Macdonald J; Benedetti J; Lokich J; Fryer J; Brufman G; Isacson R; Laplanche A; Levy E
J Clin Oncol; 1998 Jan; 16(1):301-8. PubMed ID: 9440757
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine Versus Continuous Infusion Fluorouracil for the Treatment of Advanced or Metastatic Colorectal Cancer: a Meta-analysis.
Wu Z; Deng Y
Curr Treat Options Oncol; 2018 Nov; 19(12):77. PubMed ID: 30483908
[TBL] [Abstract][Full Text] [Related]
9. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
Köhne CH; Wilke H; Schöffski P; Schmoll HJ
J Infus Chemother; 1996; 6(4):206-10. PubMed ID: 9229317
[No Abstract] [Full Text] [Related]
10. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
Benson AB
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622
[TBL] [Abstract][Full Text] [Related]
11. On prejudice and facts and choices.
Köhne CH; Folprecht G
Ann Oncol; 2006 Feb; 17(2):185-7. PubMed ID: 16428244
[No Abstract] [Full Text] [Related]
12. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
13. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study.
Aranda E; Díaz-Rubio E; Cervantes A; Antón-Torres A; Carrato A; Massutí T; Tabernero JM; Sastre J; Trés A; Aparicio J; López-Vega JM; Barneto I; García-Conde J
Ann Oncol; 1998 Jul; 9(7):727-31. PubMed ID: 9739438
[TBL] [Abstract][Full Text] [Related]
14. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
[TBL] [Abstract][Full Text] [Related]
15. Mature results of adjuvant colon cancer trials from the fluorouracil-only era.
Grem JL
J Natl Cancer Inst; 2004 May; 96(10):727-9. PubMed ID: 15150295
[No Abstract] [Full Text] [Related]
16. Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Sobrero A; Zaniboni A; Frassineti GL; Aschele C; Guglielmi A; Giuliani R; Ravaioli A; Lanfranco C; Caroti C; Arnoldi E; Barni S; Gallo L; Pessi MA; Turci D; Cortesi E; Grossi F; Frontini L; Piazza E; Bruzzi P; Labianca R
Ann Oncol; 2000 Nov; 11(11):1413-20. PubMed ID: 11142481
[TBL] [Abstract][Full Text] [Related]
17. 'Hold the Mayo': solid facts or pulp fiction?
Punt CJ
Ann Oncol; 2000 Aug; 11(8):919-20. PubMed ID: 11038025
[No Abstract] [Full Text] [Related]
18. Weekly chronomodulated 48 h infusion of high-dose 5-fluorouracil modulated by methotrexate and (6S)-leucovorin in advanced colorectal cancer: a phase IB study.
Punt CJ; Kamm YL; Wagener DJ
Anticancer Drugs; 1997 Jun; 8(5):454-8. PubMed ID: 9215607
[TBL] [Abstract][Full Text] [Related]
19. Advanced colorectal cancer: quality of life and toxicity in patients after weekly 24-hour continuous infusions of biomodulated 5-fluorouracil.
Bogliolo G; Pannacciulli I; Desalvo L; Barsotti B; Lerza R; Mencoboni M; Arboscello E
Anticancer Res; 2000; 20(1B):501-4. PubMed ID: 10769713
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
